v3.26.3
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net loss $ (157,354) $ (151,199)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of right-of-use assets 4,385 3,994
Depreciation of property and equipment 2,579 2,596
Accretion of investment premium (596) 0
Net realized loss on sale of marketable securities 4 0
Stock-based compensation expense 30,084 17,621
Changes in operating assets and liabilities:    
Accounts receivable (10,724) (8,578)
Prepaid expenses (3,161) 2,891
Other assets (2,129) 4,766
Accounts payable 3,519 (1,717)
Accrued expenses and other current liabilities (4,585) (4,594)
Deferred revenue (30,789) (13,865)
Operating lease liabilities (4,510) (5,632)
Net cash used in operating activities (173,277) (153,717)
Cash flows from investing activities    
Purchases of property and equipment (1,337) (719)
Purchases of marketable securities (236,499) 0
Sales and maturities of available-for-sale debt securities 3,085 0
Net cash used in investing activities (234,751) (719)
Cash flows from financing activities    
Proceeds from issuance of common stock pursuant to the "at-the-market" equity program, net of offering costs 0 42,573
Proceeds from the exercise of stock options 2,352 5,086
Proceeds from the ESPP 938 881
Net cash provided by financing activities 3,290 48,540
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash (6) 72
Net decrease in cash, cash equivalents, and restricted cash (404,744) (105,824)
Cash, cash equivalents, and restricted cash, beginning of period 605,874 305,838
Cash, cash equivalents, and restricted cash, end of period 201,130 200,014
Supplemental disclosure of cash flow information    
Operating lease right-of-use assets obtained in exchange for operating lease liabilities (See Note 2) $ (30,015) $ 0